Trelegy Ellipta Inhaler
Description:
- Trelegy Ellipta is a combination of three active drugs: Fluticasone Furoate, Umeclidinium, and Vilanterol.
- It is used to treat chronic obstructive pulmonary disease (COPD) symptoms such as wheezing, shortness of breath, coughing, and chest tightness in adults.
- It is also indicated to reduce the worsening of COPD in patients with a history of severe breathing symptoms.
How to use:
- Use this medicine at the same time each day as directed by your doctor.
- Do not use more than directed.
- Keep the medicine in the foil tray until you are ready to use the inhaler.
- Each time you open the cover of the inhaler and hear a click, the inhaler is ready to use. Do not close the cover until you have taken your dose.
- To inhale, breathe out fully, put the mouthpiece between your lips, and take one long, steady, deep breath in through your mouth.
- Remove the inhaler from your mouth and hold your breath for about 3 to 4 seconds, then breathe out slowly.
- Rinse your mouth out with water after inhaling.
Important information:
- Do not use if you are allergic to Fluticasone Furoate, Umeclidinium, Vilanterol, or any of the other ingredients of this medicine.
- Inform your doctor if you have any heart, liver, or respiratory problems before starting the treatment.
- Report to the physician immediately if you have any symptoms of pneumonia or other respiratory disorders after using this medicine.
- This medicine is not recommended for children or adolescents below the age of 18 years.
Side effects:
- Common side effects include cough, common cold, sore throat, diarrhea, headache, back pain, urinary tract infections, and influenza.
- Serious side effects include increased heart rate, increased blood sugar levels, decreased potassium levels, hypersensitivity reaction, fungal infections, decreased bone mineral density, cataract, glaucoma, and severe respiratory problems.
Interactions:
- Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, or herbal products you take or have taken before the treatment.
- Certain medications containing CYP3A4 inhibitors may interact with the Trelegy Ellipta inhaler and cause undesirable side effects.
Safety advice:
- Pregnancy: there is limited data regarding using Trelegy Ellipta inhaler in pregnant women. Consult your doctor.
- Breastfeeding: it is unknown whether Trelegy Ellipta inhaler are excreted in human milk. Consult your doctor.
- Liver and lung problems: talk to your doctor before using the Trelegy Ellipta inhaler if you have liver or lung problems.
- Alcohol: it is not known whether it is safe to consume alcohol with the Trelegy Ellipta inhaler. Please consult your doctor.
- Driving: it is unlikely that Trelegy Ellipta inhaler will affect your ability to drive or use machines. Please consult your doctor for more advice.
FAQ:
What if I forget to take the Trelegy Ellipta inhaler? If you miss a dose, use it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and return to your regular schedule. Do not double the dose.
What should I tell my doctor before using the Trelegy Ellipta inhaler? Inform your doctor if you are pregnant, breastfeeding, or have liver disease, heart disease, asthma, high blood pressure, heart rhythm problems, thyroid problems, or a history of eye problems. Also, inform if you are allergic to milk proteins.
Should I stop taking Trelegy Ellipta inhaler if my COPD symptoms improve? Do not stop taking Trelegy Ellipta inhaler unless told to do so by your healthcare provider because your symptoms may get worse.
How do I know I have received the dose? After you slide the cover down to expose the mouthpiece, you will hear a “click,” and the dose counter will decrease by 1 count. Even if when using the Trelegy Ellipta inhaler correctly, you may not taste or feel the medicine, and you should not take another dose.
What do the 30 means in the dose counter? Each Trelegy Ellipta inhaler contains 30 doses, which equals a 30-day supply. That’s why your dose counter starts at 30 and reduces by 1 count with each inhaled dose.
How to use Trelegy Ellipta inhaler? Trelegy Ellipta inhaler is a powder that is used with its own inhaler device. Keep the medicine in the foil tray until you are ready to use the inhaler. Each time you open the cover of the inhaler and hear a click, the inhaler is ready to use. Do not close the cover until you have taken your dose. You will lose the dose if you open and close the cover without inhaling the medicine. To inhale this medicine, breathe out fully and put the mouthpiece between your lips, and close your lips firmly around it. Take one long, steady, deep breath in through your mouth. Do not breathe in through your nose or block the air vent with your fingers. Remove the inhaler from your mouth and hold your breath for about 3 to 4 seconds, then breathe out slowly. When you have finished inhaling, rinse your mouth out with water.
Fact box:
- Molecule name: Fluticasone Furoate + Umeclidinium + Vilanterol.
- Therapeutic class: Fluticasone furoate - Corticosteroids; Umeclidinium - Anticholinergics; Vilanterol - Long-acting-beta-agonists.
- Pharmacological class: Anticholinergics; Beta2 Agonists; Corticosteroids; Inhalants; Respiratory Inhalant Combos.
- Indications: To treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.